161 related articles for article (PubMed ID: 7518762)
1. Comparative pharmacokinetics of the new oral cephalosporins.
Lode H; Fassbender M; Schaberg T; Borner K; Koeppe P
Drugs; 1994; 47 Suppl 3():10-9; discussion 19-20. PubMed ID: 7518762
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of new oral cephalosporins, including a new carbacephem.
Fassbender M; Lode H; Schaberg T; Borner K; Koeppe P
Clin Infect Dis; 1993 May; 16(5):646-53. PubMed ID: 8507756
[TBL] [Abstract][Full Text] [Related]
3. Cefetamet pivoxil clinical pharmacokinetics.
Blouin RA; Stoeckel K
Clin Pharmacokinet; 1993 Sep; 25(3):172-88. PubMed ID: 8222459
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of loracarbef and interaction with acetylcysteine.
Roller S; Lode H; Stelzer I; Deppermann KM; Boeckh M; Koeppe P
Eur J Clin Microbiol Infect Dis; 1992 Sep; 11(9):851-5. PubMed ID: 1468429
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers.
Stass H; Böttcher MF; Ochmann K
Clin Pharmacokinet; 2001; 40 Suppl 1():39-48. PubMed ID: 11352441
[TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetics of the oral cephalosporins--a review.
Wise R
J Antimicrob Chemother; 1990 Dec; 26 Suppl E():13-20. PubMed ID: 2292525
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of cefetamet (Ro 15-8074) and cefetamet pivoxil (Ro 15-8075) after intravenous and oral doses in humans.
Koup JR; Dubach UC; Brandt R; Wyss R; Stoeckel K
Antimicrob Agents Chemother; 1988 Apr; 32(4):573-9. PubMed ID: 3377466
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of intravenous cefetamet (Ro 15-8074) and oral cefetamet pivoxil (Ro 15-8075) in young and elderly subjects.
Blouin RA; Kneer J; Stoeckel K
Antimicrob Agents Chemother; 1989 Mar; 33(3):291-6. PubMed ID: 2729925
[TBL] [Abstract][Full Text] [Related]
9. Sequential therapy with intravenous and oral cephalosporins.
Janknegt R; van der Meer JW
J Antimicrob Chemother; 1994 Jan; 33(1):169-77. PubMed ID: 8157558
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacokinetics of oral cephalosporins.
Stoeckel K; Hayton WL; Edwards DJ
Antibiot Chemother (1971); 1995; 47():34-71. PubMed ID: 8554307
[No Abstract] [Full Text] [Related]
11. Influence of the antacid Maalox and the H2-antagonist cimetidine on the pharmacokinetics of cerivastatin.
Mück W; Ritter W; Dietrich H; Frey R; Kuhlmann J
Int J Clin Pharmacol Ther; 1997 Jun; 35(6):261-4. PubMed ID: 9208343
[TBL] [Abstract][Full Text] [Related]
12. Clinical pharmacokinetics of newer cephalosporins.
Klepser ME; Marangos MN; Patel KB; Nicolau DP; Quintiliani R; Nightingale CH
Clin Pharmacokinet; 1995 May; 28(5):361-84. PubMed ID: 7614776
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
Hatlebakk JG; Berstad A
Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of oral cefetamet pivoxil (Ro 15-8075) and intravenous cefetamet (Ro 15-8074) in humans: a review.
Stoeckel K; Tam YK; Kneer J
Curr Med Res Opin; 1989; 11(7):432-41. PubMed ID: 2673663
[TBL] [Abstract][Full Text] [Related]
15. Effects of antacids on the clinical pharmacokinetics of drugs. An update.
Gugler R; Allgayer H
Clin Pharmacokinet; 1990 Mar; 18(3):210-9. PubMed ID: 1969784
[TBL] [Abstract][Full Text] [Related]
16. Loracarbef: a new orally administered carbacephem antibiotic.
Force RW; Nahata MC
Ann Pharmacother; 1993 Mar; 27(3):321-9. PubMed ID: 8453172
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic and pharmacodynamic properties of histamine H2-receptor antagonists. Relationship between intrinsic potency and effective plasma concentrations.
Lin JH
Clin Pharmacokinet; 1991 Mar; 20(3):218-36. PubMed ID: 1673880
[TBL] [Abstract][Full Text] [Related]
18. The pharmacokinetics of cefadroxil over a range of oral doses and animal ages in the foal.
Duffee NE; Stang BE; Schaeffer DJ
J Vet Pharmacol Ther; 1997 Dec; 20(6):427-33. PubMed ID: 9430765
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic disposition of loracarbef in healthy young men and women at steady state.
Sitar DS; Hoban DJ; Aoki FY
J Clin Pharmacol; 1994 Sep; 34(9):924-9. PubMed ID: 7983236
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic profile of loracarbef.
DeSante KA; Zeckel ML
Am J Med; 1992 Jun; 92(6A):16S-19S. PubMed ID: 1621740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
